Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
Eudemine 50mg Tablets.
| Pharmaceutical Form |
|---|
|
White, sugar coated tablet. |
Diazoxide 50mg.
| Active Ingredient | Description | |
|---|---|---|
| Diazoxide |
Diazoxide is a peripheral vasodilator and has qualitatively the same effect on blood vessels as benzothiazine compounds, but the effect is more rapid and profound. Unlike benzothiazines, diazoxide is non-diuretic and causes retention of sodium and water. It causes a prompt increase in blood glucose by a direct inhibitory action on the secretion of insulin by the beta cells in the Islets of Langerhans. |
| List of Excipients |
|---|
|
The tablet core consists of: Lactose The tablet coating consists of: Sugar (mineral water grade) Opaglos AG-7350 consists of: Purified water |
Plastic containers with tamper evident closure containing 100 tablets.
RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
PL 36301/0021
17 December 1992 / 17 December 1997
| Drug | Countries | |
|---|---|---|
| EUDEMINE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
